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Mammalian models including non-human primates, pigs and rodents have been used
extensively to study the mechanisms of cardiovascular disease. However, there is an
increasing desire for alternative model systems that provide excellent scientific value
while replacing or reducing the use of mammals. Here, we review the use of
zebrafish, Danio rerio, to study cardiovascular development and disease. The anatomy
and physiology of zebrafish and mammalian cardiovascular systems are compared,
and we describe the use of zebrafish models in studying the mechanisms of cardiac
(e.g. congenital heart defects, cardiomyopathy, conduction disorders and regenera-
tion) and vascular (endothelial dysfunction and atherosclerosis, lipid metabolism,
vascular ageing, neurovascular physiology and stroke) pathologies. We also review
the use of zebrafish for studying pharmacological responses to cardiovascular drugs
and describe several features of zebrafish that make them a compelling model for
in vivo screening of compounds for the treatment cardiovascular disease.
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1 | INTRODUCTION
The purpose of this review is to provide an overview on the use of
zebrafish models of cardiovascular physiology and disease. We
compare the anatomy and physiology of zebrafish and mammalian
systems and briefly review the advantages of zebrafish models in
terms of gene modification and unique imaging approaches. The
manuscript then summarizes zebrafish models of cardiac pathology
with emphasis on congenital heart defects, cardiomyopathy, conduc-
tion disorders and regeneration. We then summarize zebrafish models
of vascular pathology with focus on endothelial dysfunction and
atherosclerosis, lipid metabolism, vascular ageing, neurovascular
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physiology and stroke. It should be noted that we have not have not
referenced every zebrafish study within these subject areas for the
sake of brevity. We also highlight many examples where cardiovascu-
lar research has combined pharmacological and genetic approaches,
summarize recent technological advances and how they can drive
future research in cardiovascular disease.
2 | ZEBRAFISH AND MAMMALS:
COMPARATIVE PHYSIOLOGY
2.1 | The heart
As they have a single circulatory system, zebrafish have a
2-chambered heart comprised of a single atrium and a single ventricle,
connected to the circulatory system by the bulbus arteriosus which
regulates BP to the gill vasculature. In addition to the lack of chamber
septation and the presence of the teleost-specific bulbus arteriosus,
adult zebrafish hearts are also hyper-trabeculated compared with
endothermic vertebrate hearts, with comparatively little compact
myocardium in the ventricular wall (Jensen et al., 2016). Despite the
relative simplicity of the zebrafish heart when compared with mam-
mals, most of the specialized cell types and structures (e.g. pacemaker,
atrioventricular valve, aortic valve, trabeculae and coronary
vasculature) and contributing cell types (myocardium, endocardium,
epicardium, cardiac neural crest, second heart field and fibroblasts) are
conserved. Similarly, the signalling pathways and morphogenetic
processes driving early heart development are also well conserved
(Staudt & Stainier, 2012), and zebrafish are now widely used as a
model to investigate cardiac development and morphogenesis.
Zebrafish are increasingly employed to analyse disorders of
cardiac function. Heart rate in zebrafish is more similar to human than
those of other model organisms, and ECG analysis of adult zebrafish
identifies clear P, QRS and T waves, with a QT duration that indicates
a comparable repolarization time (Milan et al., 2006), demonstrating
that electrophysiology of the adult zebrafish heart is highly similar to
human (Lin et al., 2018; Liu et al., 2016; Nemtsas et al., 2010). Despite
the small size of embryonic zebrafish hearts, techniques for measuring
ECG profile in embryos have been developed (Dhillon et al., 2013),
identifying similar ECG features from 3 days post fertilization (dpf)
onwards as those observed in adult zebrafish. Because zebrafish are
ectotherms, these electrophysiological dynamics are temperature
dependent, and thus, it is important that comparative analyses of
electrical activity in the zebrafish heart are temperature-controlled.
The similarities in ECG activity between zebrafish and human hearts,
in particular the distinct QT interval, are due to a highly comparable
ventricular action potential (AP), with both zebrafish and human
exhibiting a long plateau phase at positive voltage during repolariza-
tion. Many of the key ion channels that govern AP dynamics in human
have orthologues in zebrafish, for example, the Na+ channel encoded
by SCN5A, the inward rectifier IK,ACh K
+ channels encoded by KCNJ3
and KCNJ5, and the outward rectifying IKr K
+ channel encoded by
KCNH2. However, there are also key differences between human and
zebrafish AP dynamics and channel composition or function, with
atrial AP less similar between species, different composition of the
inward rectifier IK1 channel, and absence of delayed rectifying current
IKs-encoding genes (see Ravens, 2018). Although these similarities
make the zebrafish a highly suitable model to understand human
cardiac electrophysiology, the variation in ion channel composition
and slight differences in AP dynamics should be kept in mind during
pharmacological analyses.
2.2 | Vascular system
The basic structure of vascular anatomy is highly conserved between
zebrafish and other mammalian models, including humans (Isogai
et al., 2001). The unique advantage of the zebrafish model is that
due to the optical transparency of the embryos and larvae, the
morphological and functional changes of blood vessels can be
observed non-invasively in living animals. Developmental processes
involved in vascular development, including vasculogenesis, angio-
genesis and vascular remodelling, are comparable between zebrafish
and mammals, requiring tight regulation of the same key molecular
pathways (Gore et al., 2012). The main axial vessels, the dorsal aorta
and posterior cardinal vein form by vasculogenesis starting from
around 10 somite stage (14 h post fertilization [hpf]) from the
progenitors in the lateral plate mesoderm. The intersomitic vessels
of the trunk which are among the first angiogenic vessels to form in
vertebrates, start sprouting from the dorsal aorta from around
22 hpf. Circulating blood cells can be observed in the main axial
vessels shortly after the onset of heart contractions at 24 hpf. Even
though the cardiovascular system is one of the first to form during
development, the zebrafish embryo obtains oxygen by passive
diffusion from water for the first several days. This feature enables
studies of experimental manipulations and cardiovascular mutant
phenotypes, which would be lethal in humans and other mammals
(Stainier et al., 1996).
Important differences to be noted between fish and mammals
include the relative sparsity of mural cells associated with the
endothelium as well as low arterial BP (0.3–0.4 mmHg in larvae and
1.5–2.15 mmHg in adult zebrafish) (Michel, 2020). Nevertheless, there
seems to be a conserved response of the vasculature to the classical
vasodilators and vasoconstrictors, as well as to a number of
cardiovascular drugs (Fritsche et al., 2000; Margiotta-Casaluci
et al., 2019). Treatment of zebrafish larvae with the NO donor sodium
nitroprusside resulted in a significant increase in both arterial and
venous vessel diameters, whereas application of NOS inhibitor
NG-nitro-L-arginine methyl ester (L-NAME) led to a significant
decrease in vessel diameters, which corresponds to responses in
mammals. Similarly, in larvae pretreated with L-NAME to inhibit
endogenously produced NO, addition of adrenaline resulted in
vasoconstriction (Fritsche et al., 2000). A comparative analysis of the
in vivo cardiovascular responses of zebrafish, rat, dog and human to
three cardiovascular drugs, which modulate β-adrenergic and renin-
angiotensin systems (propranolol, losartan and captopril) showed that
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zebrafish and human responses were largely comparable in >80% of
drug/endpoint combinations, demonstrating the translational power
of zebrafish (Margiotta-Casaluci et al., 2019).
3 | ZEBRAFISH MODELS: UNIQUE
GENETIC AND IMAGING SYSTEMS
The use of zebrafish as a model to study cardiovascular function or
disease has accelerated in recent years, with a literature search
retrieving in excess of 5000 publications since 2010. This rise in popu-
larity can be attributed to several advantages the zebrafish has over
mammalian systems, primarily, the potential for examination of the
formation and function of the cardiovascular system, non-invasively,
in a live organism. Its small size, optical translucency, high fertility,
rapid development and affordability make the zebrafish an attractive
model to study human disease. Moreover, analysis of early zebrafish
embryos can in many instances replace studies of rodents and other
mammals, thereby reducing the use of more sentient animals in
research. Approximately 70% of human genes share an orthologue
with zebrafish, and 82% of known human disease genes are also
present in the zebrafish genome (Howe et al., 2013). This high degree
of conservation coupled with its amenity for genetic manipulation has
positioned the zebrafish at the forefront of biomedical research.
3.1 | The zebrafish genetic toolbox
One of the major advantages of using zebrafish in biomedical research
is the ability to perform genetic modification with relative ease. This
technology has facilitated temporal and spatial control of gene expres-
sion allowing both gain-of- and loss-of-function genetic studies. It has
been applied extensively to create transgenic lines with fluorescently
labelled cells allowing cell behaviour to be studied in unparalleled
detail. A wide range of methods are available for disrupting gene func-
tion in zebrafish for reverse genetic studies. However, these methods
have now largely been replaced by CRISPR-Cas9 mediated gene
editing, which is cheaper and simpler to implement. In addition,
gene expression can be transiently inhibited throughout the embryo
at the message or protein level using morpholino oligonucleotides
(MOs) or in specific tissues using CRISPR-Interference (CRISPRi)
(Savage et al., 2019). Genetically, zebrafish have undergone a partial
genome duplication, which can make studying the role of certain
genes more challenging due to functional redundancy of paralogous
genes. Alternatively, this redundancy can also be advantageous in
some contexts because later functions of some genes that are embry-
onically lethal in mammals can be uncovered in zebrafish.
3.2 | The imaging toolbox
The zebrafish cardiovascular system can be visualized using a multi-
tude of approaches, which range from traditional in situ hybridization
in fixed tissues to real-time analysis of transgenic reporter lines, which
express fluorescent proteins in cardiac and vascular-specific cell types.
In recent years, fluorescence microscopy techniques have shifted
towards higher resolution, increased tissue penetration depth and a
reduction of image acquisition artefacts. Although confocal and
AiryScan microscopy are often used to achieve increased in vivo
resolution, light sheet fluorescence microscopy (LSFM) has become a
crucial image acquisition method, allowing data acquisition at a
greater anatomical depth and imaging duration from hours-to-days
(Huisken et al., 2004). Of particular relevance, visualization of cardiac
dynamics has received increasing attention, allowing for 3D (+time)
data acquisition and analysis, using gating approaches in imaging and
post-processing (Mickoleit et al., 2014). Additionally, the ability to
control cardiac function optogenetically (Arrenberg et al., 2010) and
analyse endothelial cell calcium dynamics (Savage et al., 2019) has
opened up new avenues for cardiovascular studies.
4 | CARDIAC DISEASE MODELS
Zebrafish have been used to model many aspects of cardiac
development, function and disease. Here, we highlight specific
examples where zebrafish have made substantial contributions to our
understanding of cardiac defects, along with the genetic and experi-
mental techniques used to generate and interrogate these models.
Congenital heart defects (CHD) are the most common birth
defect, affecting approximately 1% of live births worldwide and
comprise a spectrum of structural malformations, including septal
defects, inflow and outflow tract malformation, chamber hypoplasia
and valve dysgenesis. Despite the comparative simplicity of the
zebrafish two-chambered heart when compared with the four-
chambered heart of mammals with dual circulatory systems, the
molecular regulation and morphogenetic processes underlying
zebrafish heart development are highly conserved. Here, we high-
light specific examples where zebrafish have provided novel insights
into CHD aetiology.
Heterotaxia syndrome is caused by perturbations in left–right
patterning of the body during embryogenesis, resulting in loss of
concordance of organ lateralization and disruption to internal
asymmetries within organ systems. The heart is a highly asymmetric
organ and correct asymmetric morphogenesis is vital for correct
cardiac function. Thus, individuals with heterotaxia often present with
CHD. Key players in the pathways regulating early establishment of
embryonic asymmetry are well established, with zebrafish mutants
exhibiting heterotaxia phenotypes similar to those present in patients
with mutations in the homologous genes (Figure 1). Recent studies
identified novel variants in candidate genes potentially causative for
heterotaxia (Liang et al., 1866; Liu et al., 2018), with functional
validation through CRISPR-Cas9-mediated embryonic mutagenesis
confirming dnah10, rnf115, flna, kif7 and kmt2d to regulate cardiac
asymmetry (Liang et al., 1866; Liu et al., 2018). Zebrafish mutant
models have also shed light on the mechanisms underlying CHDs in
individuals carrying mutations in CFAP53, encoding a ciliary protein
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(Liang et al., 1866; Liu et al., 2018; Noel et al., 2016). The genetics
underlying CHD phenotypes are complex, and this highlights the value
of zebrafish in dissecting the pathways and interactions that underlie
cardiac morphogenesis.
Zebrafish represent an excellent model to investigate the effects
of environmental factors on cardiac development. PM2.5 is fine
particulate matter, high levels of which are found in urban areas with
poor air quality or high levels of pollution. PM2.5 has been associated
with increased incidence of CHD and exposing zebrafish embryos to
PM2.5 resulted in developmental heart defects, including heart
malformations and bradycardia (Duan et al., 2017; Jiang et al., 2019;
Ren et al., 2020; Yue et al., 2017; Zhang et al., 2016). This model has
been exploited to identify compounds, which ameliorate the impact of
PM2.5 on the heart, such as folic acid. Protective effects of folic acid
on developmental heart defects have also been described in a
zebrafish model of fetal alcohol spectrum disorder (Sarmah &
Marrs, 2013), which demonstrated the negative impact of continuous
alcohol exposure during early development on cardiac morphology
and growth. Zebrafish have also been used to model the effects of
diabetes/hyperglycaemia during pregnancy on cardiac development
(Liang et al., 2010). Together, zebrafish can model the mechanisms
underlying CHDs with either genetic or environmental origins.
Cardiomyopathy represents a spectrum of heart diseases
encompassing structural changes of the myocardium, comprised of
three main classes. Dilated cardiomyopathy (DCM) is a progressive
disease characterized by an enlarged, often left, ventricle, thinning of
the myocardial wall, and reduced cardiac output. Hypertrophic cardio-
myopathy (HCM) is associated with a thickening of the ventricular
wall. Arrhythmogenic cardiomyopathy (ACM) involves degeneration
of cardiomyocytes, and gradual replacement with fibrofatty scar
tissue, affecting heart function and leading to structural heart
remodelling. Typically, cardiac function is progressively impaired,
often leading to heart failure. Hallmarks of cardiomyopathy and heart
failure are conserved in zebrafish, including the up-regulation of genes
associated with cardiomyopathy and heart failure, such as nppa/nppb
(Becker et al., 2012). Thus, studies in zebrafish have contributed
significantly to our understanding of the mechanisms underlying car-
diomyopathies through functional validation of novel cardiomyopathy
candidate genes (Figure 2). For example, a 2015 study describing
transcriptomic analysis of embryonic and adult zebrafish hearts identi-
fied zebrafish homologues for 49 out of 51 DCM-associated genes
(Shih et al., 2015).
TITIN (TTN) encodes a giant sarcomeric protein containing binding
sites for a number of proteins along its length, which associate with
the Z-disc, I- and A-bands, and M-line regions of the sarcomere.
Mutations in TTN result in both DCM and skeletal myopathy and may
account for as many as 25% of DCM cases (Herman et al., 2012).
However, the location of mutations within the TTN gene appears to
influence disease severity, with mutations in the C-terminal more
likely to be associated with profound DCM (Herman et al., 2012;
Roberts et al., 2015). Targeted CRISPR-Cas9-mediated mutagenesis in
zebrafish has shed light on why the position of truncating mutations
within TTN may influence disease severity (Zou et al., 2015). In the
latter study, the authors generated six different truncating mutations
in the zebrafish ttnb gene (which most resembles human TTN),
resulting in truncations either in the z-disc, proximal/mid I-band or
distal A-band domains. Although all mutations exhibit reduced cardiac
function, mutants with C-terminal truncations also displayed disrupted
skeletal muscle sarcomeres and paralysis. An additional promoter was
identified within an intron of ttnb, which produces a short ttnb
transcript encoding only the C-terminal of the protein and which is
expressed at higher levels in skeletal muscle than cardiac muscle.
Because this shorter C-terminal transcript is still expressed in embryos
with N-terminal truncations of full-length ttnb, this could explain why
N-terminal ttnb mutations predominantly result in cardiac defects,
whereas C-terminal mutations, which affect both transcripts, result in
cardiac and skeletal defects. This internal promoter is conserved in
mouse, and moreover, the position of this putative promoter region
lies at the border between alleles causing different phenotypic sever-
ity in the human TTN gene (Zou et al., 2015), providing insights into
F IGURE 1 Zebrafish models of congenital
heart defects. Congenital heart defects in
zebrafish are often analysed at 2 dpf, when the
heart has undergone initial looping morphogenesis
and is positioned over the yolk, ventrally and
posterior to the head. Morphology of the atrium
(A) and ventricle (V) can be distinguished, and the
atrioventricular canal and outflow tract can be
visualized. Heterotaxia phenotypes can be
assessed by the directionality of looping
morphology of the heart, which usually undergoes
a d-loop under normal left–right patterning (situs
solitus) but can be reversed (s-loop) or remain at
the midline (no-loop) if embryonic laterality is
disrupted
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why the position of genetic lesions in TTN may contribute to DCM
severity.
BLC2-associated athanogene 3 (BAG3) encodes a heat shock protein
co-chaperone implicated in DCM. Initially, morpholino-mediated knock-
down of zebrafish bag3 was performed after BAG3 CNV identification
in a DCM (Norton et al., 2011), resulting in pericardial oedema and
reduced fractional shortening in embryos, confirming a requirement for
Bag3 in heart function. However, generation of a stable zebrafish bag3
mutant revealed that although dispensable for embryonic heart
function, bag3 is required in adulthood. This is exemplified with adult
bag3 zebrafish mutants exhibiting a decline in cardiac function and
reduced exercise tolerance at 6 months (Ding et al., 2019), consistent
with DCM onset age in patients with pathogenic BAG3 variants. More-
over, functional analyses of single myofibrils, isolated from dissected
bag3 mutant zebrafish hearts, revealed defects suggestive of hypo-
contractility, a phenotype associated with DCM rather than HCM, all-
owing classification of the cardiomyopathy in bag3 mutants similar to
that employed in patients. Comparative analysis of combinatorial
bag3/mTor zebrafish mutants revealed that reduction of mTor signal-
ling can partially rescue the hallmarks of DCM observed in bag3
mutants (Ding et al., 2019). This suggests that mTor represents a candi-
date therapeutic target for bag3-associated DCM and that the bag3
mutant may represent a suitable model to screen novel compounds to
alleviate DCM associated with BAG3mutations.
The laminin/integrin/integrin linked kinase (ILK) axis links the
extracellular matrix to the cytoskeleton. The identification of a
zebrafish ilk mutant, exhibiting hallmarks of DCM, provided the first
evidence that disruptions to laminin/integrin signalling may result in
cardiomyopathy (Knoll et al., 2007). Targeted sequencing of LAMA4
and ILK in DCM cohorts subsequently revealed a missense mutation
in ILK and 10 variants in LAMA4 that were linked with DCM,
representing the first identification of laminin/integrin mutations
associated with DCM (Knoll et al., 2007).
Heterozygous mutations in ILK have also recently been linked
with ACM (Brodehl et al., 2019). In this context, generation of trans-
genic zebrafish expressing either wild type or disease variant human
ILK-GFP fusions demonstrated that these ILK variants cause fractional
shortening at 3 dpf, and specific variants result in death at juvenile
stages (Brodehl et al., 2019). Another zebrafish ilk mutant allele, main
squeeze (msq), carries a mutation in the kinase domain of ILK, and
although DCM has not been described in msq mutants, they do have
defects in cardiac contractility (Bendig et al., 2006). Protein kinase B
(PKB) phosphorylation is down-regulated in msq mutants. However,
injection of constitutively active PKB can restore heart contractility,
suggesting that PKB phosphorylation is required for heart develop-
ment. A subsequent study took advantage of this by using the msq
mutants as a tool to screen for compounds that could restore contrac-
tile function (Pott et al., 2018), identifying calyculin A and okadaic
acid as agents that could restore ventricular fractional shortening in
msq mutants, as well as partly restoring PKB phosphorylation.
The ability to perform targeted knockdown, create disease-
specific mutations or overexpress disease variants has made zebrafish
an invaluable model to validate novel candidate genes implicated in
DCM, HCM and ACM. In addition to the better-characterized genes
or pathways described above, functional studies in zebrafish have also
identified novel roles for a diverse array of genes in cardiomyopathy,
for example, Raf1, Taf1a and Asn (Dhandapany et al., 2014; Long
et al., 2017; Verhagen et al., 2019). Zebrafish DCM models have also
been generated through pharmacological induction by administering
the K+ channel blocker terfenadine to embryos (Gu et al., 2017),
whereas a zebrafish model of ACM was developed using
cardiomyocyte-driven expression of a plakoglobin disease variant,
resulting in cardiomegaly and thinning of atrial and ventricular walls in
early-adult fish (Asimaki et al., 2014). By combining this ACM model
with an nppa:luciferase transgenic line (up-regulated in ACM zebrafish
hearts), a chemical library was screened for compounds that would
F IGURE 2 Zebrafish models of
cardiomyopathy. Cardiac contractility in zebrafish
begins around 24 hpf, when the heart tube has
first formed and sarcomeres are assembled. As the
heart develops the myofilaments mature, and by
48 hpf atrial and ventricular cardiomyocytes
display different myofilament organisation.
Ventricular wall cardiomyocytes displaying cortical
basal actin while atrial cardiomyocytes forming
long myofilaments spanning the cell running
perpendicular to the direction of blood flow.
Disruptions in sarcomere assembly and function
result in diverse cardiomyopathies, represented by
zebrafish mutants or mis-expression models,
including those listed
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modify the up-regulation of nppa in the ACM model, along with
potential rescue of cardiac function. This approach identified that the
compound SB216763, a GSK-3 inhibitor, could normalize defects in
action potential observed in the ACM model (Asimaki et al., 2014),
highlighting the tractability of the zebrafish model for performing
functional screens for potential therapeutic agents which can alleviate
DCM-type phenotypes.
Conduction disorders encompass a variety of pathologies, the
precise nature of which depends on how generation or propagation of
electrical impulses throughout the heart is disrupted. Despite the rela-
tive structural simplicity of the zebrafish heart compared with that of
mammals, ECG analysis of adult zebrafish reveals that action potential
dynamics of adult zebrafish cardiomyocytes is highly similar to human
(Figure 3) (Lin et al., 2018; Liu et al., 2016; Nemtsas et al., 2010).
Recent improvements to ECG in zebrafish include refinements in
temperature considerations and the anaesthesia protocol to minimize
impacts of environmental factors on action potential analysis
(Lin et al., 2018; Yan et al., 2020), optimization of probe positioning
and opening of the pericardial sac to improve signal-to-noise ratio
(Yan et al., 2020). These efforts to standardize measurements, and
establish baseline variation in ECG parameters, allow more detailed
analysis of how arrhythmia develops in the aging animal, in genetic
models of arrhythmia, or upon inhibition of the parasympathetic ner-
vous system (Yan et al., 2020). Cardiac contractility in embryos and
adults can be captured and quantified via echocardiography (Denvir
et al., 2008; Fang et al., 2020; Wang et al., 2017), whereas cardiac
performance is also indirectly measured through exercise tolerance
using swim tunnels, where adult zebrafish undergo timed swims
against a current with increasing flow rate, and time to exhaustion is
recorded.
In addition to the similarities between zebrafish and human
cardiomyocyte action potentials, conduction dynamics in the zebrafish
heart are also sensitive to channel blockers and activators used in
humans, along with stimulants such as isoprenaline and noradrenaline
(Denvir et al., 2008; Langheinrich et al., 2003; Lin et al., 2018;
Mittelstadt et al., 2008; Nemtsas et al., 2010; Tsai et al., 2011; Yan
et al., 2020). Many of these compounds have effects on heart func-
tion or conduction similar to those observed in humans. Administra-
tion of compounds that stimulate sympathetic regulation of cardiac
function, such as noradrenaline or isoprenaline, causes tachycardia in
zebrafish (Denvir et al., 2008; Lin et al., 2018; Tsai et al., 2011),
whereas atropine, which inhibits parasympathetic input, also increases
heart rate (Yan et al., 2020). Ion channel modulators have effects on
cardiac conduction in zebrafish, similar to those seen in humans. ECG
F IGURE 3 Zebrafish models of cardiac
conduction defects. ECG recordings of embryonic
and adult zebrafish hearts closely resemble those
obtained from humans, with distinguishable P
wave, QRS complex and T wave, allowing
quantification of comparative parameters such as
QT interval. Both Long and short QT syndrome
(LQTS and SQTS) can result from mutations in the
potassium channel kcnh2, and are modelled by the
zebrafish breakdance and reggae mutants
respectively. Cardiac pacing defects such as atrial
fibrillation (AF, loss of regular sinus rhythm) and
sick sinus syndrome (SSS, defective sinus pacing,
including sinus pause) have also been modelled
using zebrafish loss of function and mis-
expression models
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analysis of embryos exposed to compounds affecting potassium
channels reveals a conserved atrial-specific response to acetylcholine
and carbachol (Nemtsas et al., 2010), whereas administration of
E4031, stemizole, terfenadine, haloperidol, diphenhydramine and
orphenadrine (hERG/KCNH2 K+ channel blockers) prolongs action
potential duration (APD) and QT interval (Dhillon et al., 2013;
Nemtsas et al., 2010; Tsai et al., 2011). Analysis of action potential
dynamics reveals that the sodium channel blocker tetrodotoxin
reduces AP upstroke (Nemtsas et al., 2010), whereas the L-type Ca
channel blocker nifedipine shortened plateau phase, shaping AP
duration (Nemtsas et al., 2010). Both nifedipine and the calcium
channel antagonist verapamil induce bradycardia (Langheinrich
et al., 2003; Lin et al., 2018), whereas BayK8644 (an L-type calcium
channel activator) prolongs QT interval (Langheinrich et al., 2003; Tsai
et al., 2011). In some cases, these compounds also induce additional
cardiac defects in a concentration-dependent manner, including
arrythmias and AV block (Dhillon et al., 2013). Conserved effects of
anti-arrhythmic drugs also been demonstrated in zebrafish, with both
amiodarone and quinidine (which can result bradycardia and prolong
QT interval) similarly prolonging QT interval in zebrafish (Lin
et al., 2018; Tsai et al., 2011; Yu et al., 2010). However, not all
compounds used in patients elicit the same response. HMR1556
(an IKS blocker) shortened APD instead of prolonging it (Nemtsas
et al., 2010), whereas the QT-prolonging drugs sotalol, erythromycin,
quinidine and amitriptyline did not have similar effect in zebrafish
(Langheinrich et al., 2003). These discrepancies could result from
some differences in ion channel composition or function or poor
uptake of the compounds. The effects of these pharmacological com-
pounds on heart function can reveal information about the molecular
pathways underlying cardiac electrophysiology in health and disease.
This is enhanced by additional imaging tools, such as genetically
encoded calcium sensors driven by myocardial promoters, which
enable live in vivo imaging of transient calcium dynamics in the
embryonic and larval heart (Chi et al., 2008; Salgado-Almario
et al., 2020; van Opbergen et al., 2018; Weber et al., 2017). Optical
voltage mapping also provides high-resolution electrophysiological
analysis of the heart. This can be achieved either through staining
with a dye (Milan et al., 2009; Panakova et al., 2010), genetically
encoded voltage sensors (van Opbergen et al., 2018), or a recently
developed myocardial mitochondrial ATP sensor (Kioka et al., 2020).
Long QT syndrome (LQTS), atrial fibrillation (AF) and sick sinus
syndrome (SSS) are conduction defects that were modelled in
zebrafish. LQTS is characterized by prolonged myocardial repolariza-
tion time, diagnosed by increased QT interval duration. Mutations in
the ion channel Kv11.1, encoded by KCNH2, are causative for LQTS,
and the zebrafish breakdance mutant, harbouring a kcnh2 mutation,
exhibits an atrioventricular (AV) block recapitulating that observed in
paediatric LQTS (Langheinrich et al., 2003). The breakdance mutant
was used as the background for a chemical screen for compounds,
which could suppress the AV block (Peal et al., 2011). Administration
of either 2-MMB or the steroid flurandrenolide shortened action
potential duration (APD) and rescued AV block in the breakdance
mutant, identifying two potential therapeutics which can shorten
myocardial repolarization. Patch clamp analysis, following the applica-
tion of the IKr potassium channel blocker terfenadine to explanted
hearts, reveals similarly increased AP duration to kcnh2 mutants, pro-
viding further functional evidence that IKr is critical for repolarization
in the zebrafish ventricle (Arnaout et al., 2007).
Despite the fact that mutations in KCNH2 are associated with
LQTS, a heterozygous variant of KCNH2 was associated with short
QT syndrome (SQTS). Expression of this KCNH2 variant in zebrafish
revealed a gain-of-function phenotype (Brugada et al., 2004), provid-
ing explanation for the opposing effect of the mutation on QT interval
when compared with conventional LQTS-associated KCNH2
mutations. The zebrafish reggae mutant provides further evidence that
specific KCNH2 variants can have opposing effects on QT interval.
Reggae mutants harbour a lesion in the voltage-sensing domain of
kcnh2 (Hassel et al., 2008). However, unlike the breakdance mutants,
reggae mutants exhibit sinus block instead of AV block (Hassel
et al., 2008; Langheinrich et al., 2003). Administration of terfenadine
reduces potassium currents and rescues the phenotype of reggae
mutants, suggesting the lesion results in gain-of-function. Supporting
this, action potential duration is significantly reduced in reggae
mutants, with a shorter QT interval (Hassel et al., 2008). Thus,
breakdance and reggae mutants represent zebrafish models of LQTS
and SQTS, with the reggae mutant representing the first described
animal model for SQTS (Figure 3).
AF is characterized by irregular atrial pacing and often increased
heart rate. Enhancer analyses in zebrafish identified putative PITX2c
regulatory sequences which overlap genetic regions containing
common AF-associated single nucleotide polymorphisms (SNPs) in
humans suggesting dysregulation of PITX2 could be causative of
AF(Ye et al., 2016). ECG analysis of adult pitx2c zebrafish mutants
reveals impaired cardiac function, accompanied by enlarged atria and
increased atrial fibrosis (Collins et al., 2019). This suggests PITX2c
variants may be a causal factor in AF.
Sick Sinus Syndrome (SSS, also termed sinus node dysfunction)
arises when the sinus node, the pacemaker of the heart, fails to
generate a regular physiological heart rate resulting in arrhythmia.
Mutations in GNB5, a guanine nucleotide-binding protein subunit
involved in recruiting proteins to inward rectifier potassium channels,
have been identified in individuals with early-onset sinus node dys-
function (Lodder et al., 2016). Analysis of the effect of carbachol and
isoprenaline on a zebrafish gnb5 mutant suggests that GNB5 is
required for parasympathetic control of heart rate, but not for sympa-
thetic control. This indicates that loss of GNB5 would be associated
with extreme bradycardia at rest - a finding in line with abnormally
low resting heart rates in patients with GNB5 mutations (Lodder
et al., 2016). Zebrafish studies validated gain–of-function activity of a
KCNJ3 variant identified in a family with autosomal dominant
bradyarrhythmia (Yamada et al., 2019), and demonstrated that
administration of the IKACh channel blocker NIP-151 improves
bradyarrhythmia phenotypes in the zebrafish model.
Functional measurements, conduction sensors and genetic
mutants all provide suitable backgrounds that can be used as the
foundation for pharmacological screens, identifying novel genes
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implicated in cardiac conduction, or compounds which modify con-
duction dynamics. A screen of almost 300 insertional mutants was
carried out to identify new genes and pathways that regulate cardiac
conduction. Cross-matching the positive hits with LQTS-associated
genome-wide association study (GWAS) data revealed a novel role for
mitotic regulator Gins3 in action potential dynamics (Milan
et al., 2009). In another study, screening of synthetic compounds that
restore heart function in tremblor mutants (a sodium-calcium
exchanger Ncx1 mutant with erratic heart contractility) revealed that
treatment with efsevin restored steady calcium transients and cell
coupling, rescuing heart function (Shimizu et al., 2015).
4.1 | Regeneration
The inability of human to replenish lost cardiomyocytes, following a
myocardial infarction (MI) results in persistent scarring, impaired heart
function, cardiac remodelling, and eventually heart failure. Although
the adult mouse heart has limited regenerative potential, neonatal
mouse hearts are able to mount a regenerative response (Porrello
et al., 2011). However, this capacity is lost by 7 days post-partum, and
long term follow-up of neonatal mice that have undergone ventricular
resection suggests long term scarring as well as dilated cardiomyopa-
thy (Andersen et al., 2016). Conversely, zebrafish are able to fully
regenerate their hearts after injury, providing an invaluable model to
understand the molecular mechanisms to improve regenerative
potential in humans. Zebrafish models of heart regeneration have pro-
vided significant insights into the temporal processes underlying
regeneration, along with the molecular mechanisms that underpin
these responses. The early response from 3 h post injury (hpi) includes
expression of proinflammatory molecules and recruitment of immune
(Bevan et al., 2020; de Preux Charles et al., 2016; Huang et al., 2013;
Simoes et al., 2020) cells, which are important for scar deposition and
the subsequent regenerative response. Simultaneously, endocardial
cells in the uninjured tissue undergo morphological changes and re-
express developmental genes (Kikuchi et al., 2011). After inflammation
and endocardial activation have occurred, the endocardium and epi-
cardium are the first cell layers to undergo large-scale regeneration.
Between 3 to 5 dpi, the endocardial cells around the injury site prolif-
erate (Munch et al., 2017), before migrating to cover the internal face
of the wound area. Onset of coronary revascularization is initiated
rapidly post-injury, and the vascular network is required to promote
regeneration (Marin-Juez et al., 2016, 2019). ECG analysis of
regenerating hearts shows that despite prolongation of QT interval
during regeneration, action potential dynamics return to normal, after
regeneration (Chablais et al., 2011; Yu et al., 2010).
Several zebrafish cardiac injury models have been established
(Figure 4), with ventricular amputation capturing the ability of the
heart to undergo regeneration, forming a fibrin clot which is gradually
replaced with muscle in 30–60 dpi (Poss et al., 2002; Raya
et al., 2003). Myocardial infarction induces death of multiple cell types
alongside inflammation and fibrosis. Thus, regeneration requires not
F IGURE 4 Zebrafish models of
regeneration. The zebrafish heart is
capable of fully regenerating after injury.
In the resection model the ventricular
apex is amputated resulting in formation
of a fibrin clot, and new heart tissue
grows within 60 days. In the cryoinjury
model, a cryoprobe is applied to the
ventricle causing localized cell death.
Inflammation and clearance of cell debris
subsequently occur, and a scar is formed
at the injury site. This scar is resolved
after around 120 days, and the heart is
regenerated
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only the replacement of lost cardiomyocytes, but also the removal of
dead cells, matrix remodelling, revascularization, and re-establishment
of electromechanical coupling in the heart (Frangogiannis, 2006). This
can be modelled in zebrafish by cryoinjury which results in substantial
localized cell death in the injured portion of the ventricle, resulting in
apoptosis of all cardiac cell types and replicating the cardiac necrosis
that occurs post-MI (Gonzalez-Rosa et al., 2011). Inducible genetic
ablation models, where cell type-specific promoters drive expression
of either diptheria toxin (DTA), or nitroreductase (an enzyme which
converts metronidazole into a cytotoxic agent) provides further
mechanistic insights into how different cell types contribute to cardiac
regeneration (Curado et al., 2007; Kefalos et al., 2019; Sanchez-Iranzo
et al., 2018; Wang et al., 2011; Zhang et al., 2013).
Interestingly, although the regenerative response to cryoinjury is
robust, scar resorption diminishes with repeated injuries and
after six cryoinjuries, hearts fail to resolve fibrotic tissue (Bise
et al., 2020). Although this demonstrates that the heart can regener-
ate after multiple insults (the ability to regenerate cardiomyocytes
themselves does not appear to be affected after multiple injuries), it
suggests there is a limit to the ability to replace the fibrotic tissue
with new cardiomyocytes. The multiple-injury model provides
opportunities to separate the pro-regenerative programme from that
of fibrosis and scar resolution, which may have implications for
improving cardiac function in MI despite the presence of scarring to
the heart.
The combination of zebrafish genetic and regeneration models
can also provide insights into how cardiac dysfunction alters regenera-
tive capacity, and how therapeutic agents may be developed to
improve this capacity. Cardiac regeneration is impaired in the
zebrafish breakdance mutant LQTS model, associated with increased
extracellular matrix (ECM) deposition and excessive inflammation
(Xu et al., 2019). Although administration of inflammatory compounds
such as dexamethasone or MMP inhibitors promotes scar resolution
and regeneration in this model (Xu et al., 2019), timing and evolution
of the immune response during regeneration is likely to be crucial in
mediating regeneration (Lai et al., 2019), and zebrafish represent an
excellent model to directly investigate how the immune response
could be manipulated to promote regeneration in humans. Similarly,
targeting ECM-remodelling represents a promising therapeutic
avenue. A 2016 study demonstrated that ECM from regenerating
zebrafish hearts has pro-regenerative effects in mammalian non-
regenerative models (Chen et al., 2016) suggesting that specific ECM
composition may be key in promoting specific aspects of regenera-
tion. In line with this, recent studies have reported that administration
of the ECM component agrin to post-MI mouse and pig hearts
improves cardiac regeneration (Baehr et al., 2020; Bassat et al., 2017),
demonstrating that insights from zebrafish can lay the foundations for
developing therapeutic strategies.
Although significant insights into cardiac regeneration have been
made using zebrafish, one limitation lies in the ability to monitor
morphological and functional recovery live, relying on fixed tissue
analyses (although light-sheet imaging facilitates visualization of
regeneration within whole-tissue context). Advances in MRI imaging
of the regenerating heart provides new opportunities to assess regen-
eration in the same animal over time (Koth et al., 2017), whereas the
development of a fluidic device to culture explanted injured hearts
allows live imaging of processes such as revascularization, providing
more detailed insights into specific cellular interactions during regen-
eration (Yip et al., 2020).
Overall, the ability to perform live, in vivo analyses of cardiac
development, function, and regeneration in zebrafish provides a
unique opportunity to define the relationships between morphological
and functional abnormalities during development, and cardiac
dysfunction and structural remodelling over the life course.
5 | VASCULAR DISEASE MODELS
5.1 | Endothelial dysfunction and atherosclerosis
Cardiovascular development is a complex and tightly regulated
process, highly conserved among vertebrates. Many of the conserved
developmental pathways regulating cardiovascular development,
including BMP, TGFβ, Notch and Wnt, are re-activated in arteries in
adults and play critical roles in the development of cardiovascular
diseases, including atherosclerosis (Souilhol et al., 2020). Thus, using
zebrafish embryos and larvae not only as a vertebrate developmental
model, but as a model for processes involved in human diseases, may
provide important insights into molecular mechanisms regulating
vascular disease (Figure 5).
Atherosclerosis is a chronic inflammatory disease that can lead to
myocardial infarction and stroke. Despite the systemic nature of many
of the associated risk factors, atherosclerosis is a focal disease
which develops in the regions of arterial trees where wall shear stress
(WSS) magnitude is low and flow patterns are disturbed, this is
particularly the case at vessel bends, branches and bifurcations.
Disturbed flow and low WSS activate endothelial cells (ECs) leading to
a pro-inflammatory, proliferative, and pro-apoptotic phenotype,
contributing to endothelial injury and leading to development of
atherosclerotic lesions. In contrast, laminar, unidirectional flow and
physiologically high WSS confer a protective, quiescent phenotype to
ECs. Transparency of the zebrafish embryos combined with availabil-
ity of transgenic lines allow imaging and measurement of blood flow
parameters and haemodynamic forces in the developing zebrafish
vasculature using digital particle image velocimetry (DPIV) and
computational fluid dynamics (CFD). These studies indicate that WSS
magnitudes in the zebrafish vasculature are comparable to those in
humans, with Lee et al. reporting the mean WSS in the dorsal aorta
between 4 and 8 dyne cm-2 and in the caudal vein between 1 and
2 dyne cm-2 at 15 dpf (Lee et al., 2015). In contrast, WSS magnitudes
in mice are approximately 10 times higher than in humans, primarily
due to differences in size and heart rate. (Suo et al., 2007)
Although zebrafish have been used to study the roles of flow and
WSS in vascular development and remodelling (Baeyens et al., 2015;
Franco et al., 2015; Geudens et al., 2019; Goetz et al., 2014; Gray
et al., 2013; Lenard et al., 2015; Weijts et al., 2018) endothelial
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responses to flow, relevant for development of atherosclerosis,
require further examination. In a recently established zebrafish model
of flow-mediated EC apoptosis, preventing blood circulation using
tnnt2a morpholino (silent heart embryos) or the anaesthetic tricaine,
resulted in increased EC apoptosis in the vascular plexus of embryos
(Serbanovic-Canic et al., 2017). The model was subsequently used for
functional validation of a number of putative apoptotic regulators
found to be enriched at a disease-prone site. It will be of interest to
determine whether haemodynamic forces have an effect on other
features of EC dysfunction in zebrafish, such as proliferation and
inflammatory responses.
Reduction of viscosity-dependent shear stress in zebrafish
embryos decreased induction of the glycolytic metabolite, dihydroxy-
acetone by flow-sensitive VEGFR-PKCε-PFKFB3 signalling. This led
to impaired vascular regeneration following zebrafish tail amputation,
whereas injecting erythropoietin mRNA to increase shear stress
promoted vascular repair (Baek et al., 2018). In conclusion, zebrafish
embryos can model several features that are important in the patho-
genesis of atherosclerosis including EC apoptosis, impaired vascular
repair and regeneration.
5.2 | Lipid metabolism
In addition to haemodynamic factors, lipid metabolism plays an impor-
tant role in atherosclerosis development. Accumulation of LDL, the
main carrier of cholesterol, in the subendothelial layer and its subse-
quent oxidation into oxidized LDL triggers inflammatory and immune
responses, which initiate plaque formation. Interestingly, feeding
zebrafish a high cholesterol diet (HCD) can replicate some of the
processes involved in the early stages of atherosclerosis, such as
hypercholesterolaemia, lipoprotein oxidation, vascular lipid accumula-
tion and myeloid cell recruitment to the vasculature (Stoletov
et al., 2009). Feeding of HCD to zebrafish for up to 10 days starting
from 5 dpf resulted in increased expression of inflammatory markers
TNF-α and IL-1β, as well as decreased expression of the gene for the
anti-inflammatory protein PPARγ in the endothelium, prior to myeloid
cell accumulation and lipid deposition (Luo et al., 2019).
So far, two zebrafish genetic models of hyperlipidaemia have
been reported: apolipoprotein C-II (apoc2) and LDL receptor (ldlr)
mutants, which have been generated using TALEN- and CRISPR/
Cas9-mediated genome editing, respectively (Liu et al., 2015, 2018).
F IGURE 5 Zebrafish embryos and larvae can be used to study vascular responses to flow, high fat feeding and as models of intracerebral
haemorrhage. (a) Blocking blood flow leads to increased endothelial cell apoptosis in the aorta and caudal vein plexus of zebrafish embryos at
30 h post fertilisation (hpf). Whole-mount active caspase-3 (red) staining of 30 hpf flk1:EGFP-NLS zebrafish embryos (green EC nuclei) in the
presence or absence of flow (sih morpholino oligonucleotide). Apoptotic ECs are shown in yellow. (b) Vascular injury by tail amputation at 3 days
post fertilization (dpf) results in shear stress-dependent vessel repair and regeneration by 3 days post amputation (dpa), which is impaired upon
exposure to ultrafine particles (UFP). Control fish developed vascular regeneration connecting the dorsal aorta with the dorsal longitudinal
anastomotic vessel at 3 dpa (yellow arrow). Fish exposed to UFP developed impaired vascular repair and a disrupted vascular network (red
arrows) at 3 dpa. (c) Vascular lipid deposits in 14 dpf wildtype (WT) and apoc2 mutant larvae (apoc2/) fed a normal diet. (d) Exposure of
zebrafish embryos to atorvastatin (ATV) results in intracranial haemorrhage. Bleeds are formed in both forebrain and mid-hindbrain regions
(arrows denote haemorrhages). (b) Images kindly provided by Prof. Tzung Hsiai. Images adapted from Liu et al. (2015) (c) and Crilly et al. (2018)
(d) under Creative Commons Licence
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In accordance with the phenotype observed in human patients with
APOC2 deficiency, Apoc2 zebrafish mutants fed a normal diet
displayed hypertriglyceridaemia, which was rescued by injection of
plasma from wild-type zebrafish or by injection of a human APOC2
mimetic peptide. Apoc2-deficient zebrafish larvae exhibited
accumulation of lipid and lipid-laden macrophages in the vasculature,
in resemblance to early human and mouse atherosclerotic lesions (Liu
et al., 2015). dlr mutants, on the other hand, developed moderate
hypercholesterolaemia when fed a normal diet, which was exacer-
bated following a short-term, 5 day HCD feeding starting at 4.5 dpf
(Liu, Kim, et al., 2018). Therefore, hyperlipidaemia can be modelled
in zebrafish using either dietary and genetic approaches, and
such models can be useful for screening of novel lipid-lowering
compounds.
Vascular ageing is a significant and independent risk factor for a
range of degenerative diseases, including cardiovascular diseases.
Vascular ageing is characterized by increased endothelial dysfunction
and medial wall calcification, contributing to arterial stiffness (North &
Sinclair, 2012). Zebrafish are an attractive model for studying age-
related diseases, due to their short life span, which is similar to that of
mice, and conservation of mechanisms involved in DNA damage repair
and regulation of telomere length. Interestingly, telomere shortening
in vivo has been observed in the regions susceptible to atherosclerosis
and telomere lengths are shorter in atherosclerotic plaques compared
with healthy vessels (Salpea & Humphries, 2010), indicating a role for
telomere homeostasis in the pathogenesis of atherosclerosis.
5.3 | Neurovascular physiology and stroke
Due to the combination of larval transparency, experimental
accessibility of embryos and experimental tools available, zebrafish
have become a crucial model to study neurovascular development.
This is exemplified by the ability to study blood–brain-barrier (BBB)
formation in vivo and over time (Eliceiri et al., 2011; Fleming
et al., 2013; Quinonez-Silvero et al., 2020; van Leeuwen et al., 2018;
Xie et al., 2010), showing that BBB formation and cerebrovascular
angiogenesis occur in parallel (Umans et al., 2017) and the identifica-
tion of functional and genetic regulators for BBB formation (Bostaille
et al., 2016; O'Brown et al., 2019; Vanhollebeke et al., 2015). Recent
work showed that a functional interaction between the brain vascula-
ture and neurons (i.e. neurovascular coupling, NVC) develops in
zebrafish between 6 and 8 dpf (Chhabria et al., 2020), establishing the
first non-rodent model to study NVC. Similarly, careful observations
revealed the existence of perivascular cells (Venero Galanternik
et al., 2017), shed light on vascular mural cell coverage (Ando
et al., 2016; Whitesell et al., 2019), established the dynamics of
cerebrovascular spinal fluid movements (Olstad et al., 2019), and
discovered a new endothelial cell membrane behaviour, termed kugeln
(Kugler et al., 2019). Increasing understanding in vascular diseases and
the ability to model those in zebrafish, such as stroke (Crilly
et al., 2019) or thrombosis (Freire et al., 2020), sheds light on vascular
bed-specific disease progression, such as vascular dementia.
Additionally, we are beginning to understand how vascular regulation
develops (Bahrami & Childs, 2020). This is complemented by studies
examining the role of blood flow on cerebrovascular patterning and
cell death, as well as novel computational analysis approaches, which
bridge the gap between data acquisition and extraction of meaningful
results for clinical translation using quantitative objective image analy-
sis (Daetwyler et al., 2019).
Ischaemic stroke, which results from occlusion of cerebral blood
vessels, accounts for 85% of all acute strokes. On the other hand,
haemorrhagic stroke, caused by intracerebral haemorrhage, is less
common (15%), but it is associated with higher morbidity and mor-
tality rates. There have been a limited number of studies attempting
to establish a zebrafish model for studying ischaemic stroke (Walcott
& Peterson, 2014). In contrast, zebrafish have more extensively been
used to study intracerebral haemorrhage. Thus, bleeding in the brain
of zebrafish larvae induced quantifiable pathological and inflammatory
phenotypes which mimicked key features of human intracerebral
haemorrhage (Crilly et al., 2018). One of the advantages of zebrafish
over mammalian models is the ability of zebrafish larvae to exhibit
spontaneous brain-specific bleeding which can be observed noninva-
sively. Intracerebral haemorrhage can result from genetic mutations
(arhgef7, pak2a and notch3) or can be induced pharmacologically (with
atorvastatin) (Eisa-Beygi et al., 2013; Withers et al., 2020). However,
there are limitations to using the zebrafish model which include the
lack of fully developed cranium and rapid recovery rates from brain
injury (Crilly et al., 2018).
6 | CARDIOVASCULAR DRUG DISCOVERY
AND FUTURE DIRECTIONS
Despite considerable advances in therapeutic approaches, cardiovas-
cular diseases are still the leading cause of death worldwide. The
zebrafish model offers exciting possibilities for drug discovery by
combining advantages of both in vitro systems (including cost, size,
ease of use and amenability to automation) and mammalian systems,
as a holistic and physiologically relevant model with high level of
genetic and functional conservation between zebrafish and humans
(Novodvorsky et al., 2013).
However, limitations of the zebrafish model must also be consid-
ered. Firstly, high throughput screening is limited to water-soluble
compounds that can be added to the water in which the fish develop.
Additionally, due to solubility issues, especially at higher compound
concentrations, it may be challenging to predict the relationship
between administered compound dose and actual exposure. Although
methods for robotic injection into the zebrafish yolk are available and
suitable for injection of DNA, microbes or cells (Spaink et al., 2013),
microinjection into the blood circulation is less amenable for high
throughput applications. Secondly, lack of standardized protocols,
including zebrafish strains, husbandry practices and experimental
design, can lead to experimental variability and lack of reproducibility
(Hamm et al., 2019). Despite these limitations, there are currently
eight compounds discovered in zebrafish that have advanced into
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clinical trials which demonstrates the translational value of the
zebrafish model (Cassar et al., 2020). The combination of genetic and
pharmacological models mimicking human cardiac dysfunction
(including advances in genome-editing which allow the creation of
human disease-specific variants in zebrafish), high resolution live
in vivo imaging, electrophysiological analysis of cardiac function, and
high-throughput screening capacity, position the zebrafish as an
excellent translational model. This is exemplified by screens identify-
ing compounds which improve cardiac function in specific zebrafish
cardiomyopathy models (Asimaki et al., 2014; Peal et al., 2011; Pott
et al., 2018; Shimizu et al., 2015; Yamada et al., 2019), providing the
foundation for further investigation.
Recent technological advancements allow for fully automated
high throughput screening assays, with robotics-mediated handling
steps and automated image acquisition and analysis. Burns et al
established a 96-well-based assay for measuring heart rate using
automated microscopy of Tg (cmlc2:GFP) embryos expressing GFP
specifically in the myocardium (Burns et al., 2005). Some of the
challenges, such as the requirement for anaesthesia or restraint,
fluorescently labelled animals, as well as the level of throughput, have
been addressed in subsequent studies (Gierten et al., 2020; Martin
et al., 2019). A wide range of cardiovascular parameters, including
heart rate, rhythm, contractility, vessel diameter and blood circulation,
can now be assessed automatically or semi-automatically using
96-well or 384-well format (Kithcart & MacRae, 2017).
In addition to drug discovery, the zebrafish is also a valuable
model for cardiotoxicity studies. Cardiotoxicity, manifested by
conduction abnormalities, arrhythmias and depression of myocardial
contractility is a serious side effect of many drugs which can limit their
clinical application. One small molecule screen in zebrafish found that
22 out of 23 tested compounds which cause QT interval prolongation
in humans, caused bradycardia and atrioventricular block in the
zebrafish, demonstrating suitability of the zebrafish model (Milan
et al., 2003). An example of a cardiotoxic agent is doxorubicin, a
highly effective chemotherapy drug, the use of which is limited by
cumulative, dose-related myocardial damage which can lead to heart
failure. Using a zebrafish model of doxorubicin-induced cardiomyopa-
thy for small-molecule screening, the cytochrome P450 family, CYP1,
has been recently identified as a candidate therapeutic target for
clinical cardioprotection (Asnani et al., 2018; Lam et al., 2020).
Zebrafish, first introduced as a developmental model in 1970s,
have become an increasingly attractive and valuable model for
studying human diseases. With its unique advantages, the zebrafish
model has proven its utility in studying disease mechanisms, drug
screenings and toxicology studies, complementing murine models and
in vitro systems. With the emergence of large amounts of data
generated by human–omics studies, the identification of new, robust
and reliable zebrafish models for functional screening of genes with
putative roles in cardiovascular health and disease is required.
Zebrafish are emerging as a valuable model for functional validation
of GWAS data from patients with diverse cardiovascular disease,
providing additional disease-specific models which can inform
therapeutic development (von der Heyde et al., 2020).
Despite its amenability to high throughput screening, automated
imaging and phenotypic scoring still remain a challenge. Continued
technological advances and application and development of
automated zebrafish screening platforms will increase the clinical
significance of the zebrafish model, leading to a better understanding
of disease mechanisms and new therapeutic targets for human
diseases, including cardiovascular disease.
6.1 | Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked
to corresponding entries in the IUPHAR/BPS Guide to
PHARMACOLOGY (http://www.guidetopharmacology.org) and are
permanently archived in the Concise Guide to PHARMACOLOGY
2019/20 (Alexander, Cidlowski, et al., 2019; Alexander, Fabbro,
et al., 2019a; 2019b; Alexander, Kelly, et al., 2019; Alexander, Mathie,
et al., 2019).
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